Loading...
NPI 1841375094 · New Haven, CT · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Precipio Inc is a clinical medical laboratory provider located in New Haven, Connecticut. This profile covers 45 Medicare and 17 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Precipio Inc |
| Address | 4 Science Park Ste 3 |
| City | New Haven |
| State | CT |
| ZIP | 06511 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | October 26, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $3.3M |
| Medicaid | $291.5K |
PRECIPIO INC's code mix is concentrated in specialized pathology and hematology/oncology diagnostics: high-volume flow cytometry codes (88185, 88189, 88184) and multiple in situ hybridization/immunostain pathology codes (88377, 88369, 88368, 88366) dominate its billed services, and molecular/genomic panel codes such as 81455 and 81479 also appear in the Medicare mix. This pattern of codes is consistent with a clinical medical laboratory that performs complex diagnostic testing and pathologist interpretation rather than routine clinical chemistry or primary-care laboratory work.
Medicare revenue is highly concentrated: the top three Medicare codes (88377, 88185, 88313) together account for 61.8% of this provider's total Medicare revenue. Individually those codes generate sizable Medicare receipts (88377 $893.1K, 88185 $814.8K, 88313 $211.8K), indicating reliance on a small set of high-value diagnostic procedures for the bulk of Medicare income.
Medicaid revenue is even more concentrated: the top three Medicaid codes (88185, 88377, 88189) account for 80.6% of the provider's total Medicaid revenue. The largest Medicaid contributions come from 88185 ($121.8K, 41.8%) and 88377 ($98.9K, 33.9%), showing that the same specialized testing lines drive revenue across payers.
Payer mix is heavily Medicare-skewed: lifetime Medicare revenue is $3.3M versus $291.5K in Medicaid, so Medicare billing dominates the provider's volume and financial footprint. While the provider does bill Medicaid, Medicaid represents a much smaller share of its lifetime public-payer revenue.
For multiple high-revenue Medicare codes the provider is a national-scale outlier: 88377 ranks #9 of 616 providers nationally (99th percentile; extreme outlier) and 88185 ranks #9 of 618 providers nationally (99th percentile; extreme outlier), with other codes such as 88189 and 88369 also flagged as extreme outlier or notably above typical. These national rankings indicate the provider is a dominant/major participant in several specialized pathology and flow-cytometry services versus typical national peers.
On a state Medicaid basis the provider shows leadership for specific tests: 88377 ranks #1 of 2 providers in-state (100th percentile) and several in situ hybridization codes (88369, 88368) also rank at the top of the small in-state peer set. At the same time, Medicaid ranking for 88185 is more modest (#4 of 10 in-state, 67th percentile), so the provider is a leading in-state supplier for certain ISH pathology services but not uniformly dominant across all Medicaid test lines.
Multiple codes are explicitly labeled as outliers in the supplied data (e.g., extreme outlier for 88377, 88185, 88189; notably above typical for 88341 and 88184), which supports an interpretation that this lab receives unusually high volumes of complex diagnostic specimens and likely functions as a specialized or high-throughput pathology center rather than a general-purpose lab. The presence of both high-volume flow cytometry claims (88185: 38.8K Medicare claims) and niche genomic tests (81455: 41 Medicare claims at high per-claim payment) underscores a mix of high-throughput technical work and episodic high-value molecular testing.
The provider has long tenure in national enrollment (NPI enumerated on 2006-10-26 (~20 years ago)), which combined with the large claim counts reported (for example 38.8K Medicare claims for 88185 and 2.7K Medicare claims for 88377) suggests sustained operational capacity over time to support its concentrated, specialty-heavy billing profile. This longevity increases confidence that the observed concentration and outlier status reflect an established service-line focus rather than a transient reporting anomaly.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
45 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 88377 | The lab analyst applies a single multiplex in situ hybridization probe stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a… | 2,670 | $340 | $893.1K |
| 88185 | The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with… | 38,800 | $20 | $814.8K |
| 88313 | The lab analyst performs the technical lab steps to stain a specimen for Group II identification, for example an iron stain or trichrome stain. A qualified provider, typically a pathologist,… | 3,070 | $70 | $211.8K |
| 88341 | The lab analyst applies an additional single antibody stain on a slide or slides prepared from the same patient specimen as the initial antibody stain, such as tumor tissue. Then a qualified… | 1,880 | $70 | $135.4K |
| 81455 | The lab analyst performs a genomic sequence analysis panel to evaluate the patient specimen, such as tumor tissue or bone marrow, for DNA and possibly RNA alterations in 51 or more genes known to… | 40 | $2,860 | $117.3K |
| 88189 | The clinician, typically a pathologist, interprets flow cytometry results of 16 or more markers. | 1,530 | $70 | $105.8K |
| 88369 | The lab analyst applies an additional in situ hybridization single probe stain on a slide or slides prepared from the same patient specimen as the initial probe stain, such as tumor tissue. Then a… | 990 | $100 | $102K |
| 88184 | The lab analyst performs the technical component of a flow cytometry procedure using a cell surface, cytoplasmic, or nuclear marker to characterize cells and aid clinicians in diagnosing patients… | 1,400 | $60 | $88.5K |
| 88368 | The lab analyst applies an initial in situ hybridization single probe stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a… | 520 | $120 | $62.5K |
| 88237 | The lab analyst performs a procedure to grow a culture of cells from bone marrow or blood in a neoplastic disorder. | 410 | $140 | $58.1K |
Showing 1–10 of 45
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 45 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
45 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 88185 | 2 | 10 | 32,650 | $20 | $642.3K |
| 88377 | 1 | 10 | 30 | $300 | $134.4K |
| 81455 | 2 | 10 | 50 | $2,860 | $131.6K |
| 88184 | 2 | 10 | 1,290 | $60 | $81.1K |
| 88237 | 3 | 10 | 460 | $140 | $64K |
| 88366 | 1 | 10 | 250 | $240 | $58K |
| 81207 | 2 | 10 | 330 | $140 | $46.7K |
| 88305 | 58 | 200 | 410 | $40 | $44.6K |
| 81338 | 1 | 10 | 270 | $150 | $40.1K |
| 88369 | 1 | 10 | 140 | $100 | $39K |
Showing 1–10 of 45
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
17 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 88185 | The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with… | 1,500 | $80 | $121.8K |
| 88377 | The lab analyst applies a single multiplex in situ hybridization probe stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a… | 920 | $110 | $98.9K |
| 88189 | The clinician, typically a pathologist, interprets flow cytometry results of 16 or more markers. | 1,570 | $10 | $14.1K |
| 85060 | The physician, typically a clinical pathologist, performs a peripheral blood smear review and provides an interpretation and written report of the examination. | 420 | $30 | $12.2K |
| 88184 | The lab analyst performs the technical component of a flow cytometry procedure using a cell surface, cytoplasmic, or nuclear marker to characterize cells and aid clinicians in diagnosing patients… | 1,500 | $10 | $12K |
| 88369 | The lab analyst applies an additional in situ hybridization single probe stain on a slide or slides prepared from the same patient specimen as the initial probe stain, such as tumor tissue. Then a… | 310 | $30 | $8.5K |
| 88368 | The lab analyst applies an initial in situ hybridization single probe stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a… | 580 | $10 | $6.3K |
| 81279 | The lab analyst performs the technical lab test on a specimen such as blood to analyze specific gene sequences of the JAK2 (Janus kinase 2) gene, such as exons 12 and 13, which may be associated with… | 210 | $20 | $3.2K |
| 81208 | The lab analyst performs the technical lab test to evaluate BCR/ALB1 gene sequences that occur on chromosome 22 at breakpoints other than the major and minor breakpoints due to translocation, which… | 90 | $30 | $2.6K |
| 81338 | The lab analyst performs the technical lab test on a specimen such as blood to analyze common variants of specific gene sequences of the MPL (MPL proto–oncogene, thrombopoietin receptor) gene, such… | 210 | $10 | $2.6K |
Showing 1–10 of 17
How this provider's Medicaid billing volume and revenue compare to other Connecticut providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Connecticut median
17 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 88184 | The lab analyst performs the technical component of a flow cytometry procedure using a cell surface, cytoplasmic, or nuclear marker to characterize cells and aid clinicians in diagnosing patients… | 4 | 10 | 650 | $80 | $188.6K |
| 88185 | The lab analyst performs the technical component of a flow cytometry procedure using cell surface, cytoplasmic, or nuclear markers to characterize cells and aid clinicians in diagnosing patients with… | 4 | 10 | 630 | $60 | $132.7K |
| 88377 | The lab analyst applies a single multiplex in situ hybridization probe stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a… | 1 | 10 | 810 | $100 | $77.3K |
| 88237 | The lab analyst performs a procedure to grow a culture of cells from bone marrow or blood in a neoplastic disorder. | 4 | 10 | 420 | $60 | $51.2K |
| 88189 | The clinician, typically a pathologist, interprets flow cytometry results of 16 or more markers. | 4 | 10 | 170 | $30 | $47.5K |
| 85060 | The physician, typically a clinical pathologist, performs a peripheral blood smear review and provides an interpretation and written report of the examination. | 5 | 10 | 390 | $10 | $23.4K |
| G0452 | Molecular pathology procedure; physician interpretation and report | 3 | 10 | 1,030 | $10 | $20.4K |
| 88291 | A qualified provider, typically a pathologist, submits an interpretation and report of cytogenetic and molecular cytogenetic testing commonly performed by lab analysts. | 3 | 10 | 1,750 | $10 | $17.2K |
| 81206 | The lab analyst performs the technical lab test to evaluate the major breakpoint gene sequence BCR/ALB1 that occurs on chromosome 22 due to translocation, which involves breakage and reforming of an… | 4 | 10 | 120 | $20 | $15.9K |
| 81207 | The lab analyst performs the technical lab test to evaluate the minor breakpoint gene sequence BCR/ALB1 that occurs on chromosome 22 due to translocation, which involves breakage and reforming of an… | 3 | 10 | 380 | $20 | $13.4K |
Showing 1–10 of 17
Other providers in the same ZIP code as Precipio Inc, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.